Computer scientists use artificial intelligence to predict the frequencies of drug side effects

ai
Credit: CC0 Public Domain

A new algorithm has been developed by academics at Royal Holloway, University of London, to predict the side effects of drugs before they hit the market by using the same principle by which movies are recommended to users.

The machine learning approach, by Dr. Diego Galeano and Professor Alberto Paccanaro, from the Department of Computer Science at Royal Holloway, is the first of its kind to be able to predict the percentage of the population that will be affected by a specific side effect elicited by a drug.

At present, it is well recognized that numerous side effects of medical drugs are not observed during , but are only identified after the drug has reached the patients, which can cause significant morbidity and mortality in healthcare.

By using an algorithm similar to that of Netflix, which predicts its users taste in films and then suggest movies to watch, the will help to determine how people will react to a drug and the percentage of people who will have side effects after the first stages of human trials, and therefore direct the trial going forward.

Professor Alberto Paccanaro from Royal Holloway said, "It is extremely important to predict what the frequencies of the side effects of the drugs will be after the first stages of clinical trials. At the moment, we don't have any systems that can do this."

While the accurate estimation of the frequencies of side effects is vital to in the , it is also essential for as it reduces the risk of drug withdrawal from the market or of a costly reassessment of side effect frequencies through new clinical trials.


Explore further

Predicting potential pharma side effects

Citation: Computer scientists use artificial intelligence to predict the frequencies of drug side effects (2020, September 11) retrieved 29 September 2020 from https://techxplore.com/news/2020-09-scientists-artificial-intelligence-frequencies-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
104 shares

Feedback to editors

User comments